Reaction to the recommendation has been strong and mostly—but not entirely—negative. 

If we would just let it do its thing, AI could fix practically everything that’s wrong with U.S. healthcare. 

Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.

The Department of Health and Human Services has unfurled a roadmap for aligning its approach to AI adoption in healthcare with the broad AI aspirations of President Trump. 

The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.

The allegation came days after an internal FDA memo linked the vaccines to the deaths of multiple children. A group of former FDA commissioners pushed back against the content of that memo.

According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.

The Health Tech Investment Act would assign all U.S. FDA-cleared AI devices to a new classification under the hospital outpatient payment system.